Local News: Los Angeles, CA 

 | 

Sign Up

 | 

Sign In

Watson Pharmaceuticals News Editors

News Widget

Display the Watson Pharmaceuticals news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Watson Pharmaceuticals News

News on Watson Pharmaceuticals (Ticker: WPI) continually updated from thousands of sources around the net.

2 hrs ago | Freshnews

Watson to Present at Goldman Sachs Global Healthcare Conference 2012

PARSIPPANY, N.J., May 29, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. , a leading specialty global pharmaceutical company, announced today that Paul Bisaro, Watson's President and Chief Executive Officer, will provide an overview and update of the Company's business at the Goldman Sachs Global Healthcare Conference 2012 on Wednesday, June 6, ... (more)

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Rancho Palos Verdes, CA, Marketing

6 hrs ago | Wall St. Cheat Sheet

Healthcare Business Recap: Human Genome Sciences Shareholder Sues,...

The board of Human Genome Sciences is being sued by a shareholder, and the court is being petitioned to stop the company from using its "poison pill" to prevent the $2.6 billion hostile takeover attempt by GlaxoSmithKline .

Comment?

Related Topix: Biotech, Human Genome Sciences, Medicine, Healthcare Industry, Endo Pharmaceuticals Holdings, GlaxoSmithKline, Pharmaceuticals

10 hrs ago | CBS News

Mylan starts selling generic Lipitor in the US

PITTSBURGH &#8212 Mylan Inc. said Tuesday it is now selling a generic version of Pfizer's cholesterol drug Lipitor.

Comment?

Related Topix: Medicine, Lipitor, Atorvastatin (generic), Medication, Pfizer, Biotech, Healthcare Industry, Cholesterol, Health, Healthcare Law, Law, Pharmaceuticals, Sepracor

17 hrs ago | Medical News

Watson, Endo and Teikoku Seiyaku enter settlement agreement to resolve Lidoderm patent litigation

Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has entered into an agreement with Endo Pharmaceuticals Inc.

Comment?

Related Topix: Biotech, Medicine, Endo Pharmaceuticals Holdings, Healthcare Industry, Pharmaceuticals, Food and Drug Administration, Health

Sat May 26, 2012

Wall St. Cheat Sheet

Healthcare Business Recap: Express Scripts New Driver, Elan Pops

Early benefits from Express Scripts Holding's huge acquisition of Medco are being seen, such as a large windfall fromlower priced deals from manufacturers, and the lesser returns from the adoption of Medco's postage-rate strategy.

Comment?

Related Topix: Biotech, Elan Corporation Plc, Social Solutions, Express Scripts, Medco Health Solution, Insurance, Rosetta Genomics, Medicine, Pharmaceuticals, Healthcare Industry

Fri May 25, 2012

BioSpace

Watson Pharmaceuticals, Inc. to Present at the Jefferies and Co. 2012 Global Healthcare Conference

The presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Website at http://ir.watson.com . The webcast can also be accessed at the following URL: An archived version will be available approximately one hour after the live presentation ends and can be accessed at the same locations for 90 days.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Investment Banking, Financial Services, Jefferies Group, Investment Services

Thu May 24, 2012

BioSpace

Auxilium Pharmaceuticals and File Lawsuit Against Watson...

Auxilium Pharmaceuticals and FCB I LLC File Lawsuit Against Watson Laboratories, Inc.

Comment?

Related Topix: Biotech, Auxilium Pharmaceuticals, Medicine, Pharmaceuticals, Healthcare Industry, Marketing

Reuters

Auxilium sues Watson on testosterone gel patent

Auxilium Pharmaceuticals Inc sued Watson Pharmaceuticals Inc alleging that it infringed patents related to Auxilium's testosterone gel Testim.

Comment?

Related Topix: Biotech, Auxilium Pharmaceuticals, Medicine, Pharmaceuticals, Healthcare Industry

Tue May 22, 2012

AmericanBankingNews.com

Canaccord Genuity Reiterates "Buy" Rating on Watson Pharmaceuticals Incorporated

's stock had its "buy" rating restated by analysts at Canaccord Genuity in a research report issued to clients and investors on Tuesday.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Investment Banking, Financial Services, Jefferies Group, Investment Services, Banking, Bank of America

Customer Interaction Solutions

NTRR Orders Initial Manufacturing Run of New pH Balance Formulas

Neutra Corp. , an emerging nutraceuticals provider, took a major step toward delivering its innovative new pH balance supplement to market by ordering an initial manufacturing run of two new formulas for testing.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry

Mon May 21, 2012

SchaeffersResearch.com

Elementary, My Dear Watson Pharmaceuticals

As major indices bounced higher today following persistent selling over the past several weeks, I continued to rebuild my watchlist for potential long candidates.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Parsippany, NJ, Day Trading, Financial Markets, Personal Finance

BioSpace

Watson Pharmaceuticals, Inc. to Present at the 28th Annual Strategic Decisions Conference

The presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Website at http://ir.watson.com . The webcast can also be accessed at the following URL: http://cc.talkpoint.com/bern001/053012a_ad/?entity=3_745CNR5 An archived version will be available approximately one hour after the live presentation ends ... (more)

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pharmaceuticals, Sanford C. Bernstein

Fri May 18, 2012

Customer Interaction Solutions

Watson to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference

PARSIPPANY, N.J., May 18, 2012 /PRNewswire via COMTEX/ -- Watson Pharmaceuticals, Inc.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Sanford C. Bernstein

BioSpace

Warner Chilcott, PLC Sues Watson Pharmaceuticals, Inc. Over Generic Contraceptive

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Warner Chilcott Plc , the maker of dermatology and women's health drugs, sued Watson Pharmaceuticals Inc.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Dermatology

Tue May 15, 2012

Business Journal

Anda laying off Ohio employees before move to Memphis area

A New Jersey pharmaceutical company plans to lay off 55 Central Ohio employees this summer as it prepares to move its Groveport distribution center to the Memphis area, Business First reports .

Comment?

Related Topix: Parsippany, NJ, Biotech, Medicine, Pharmaceuticals, Healthcare Industry

Fri May 11, 2012

Seeking Alpha

Pfizer Set To Surge On 3 New Drug Candidates

Lipitor , marketed by Pfizer to reduce blood cholesterol levels, has been the best-selling pharmaceutical of all time, with aggregate sales of over $125 billion and still going.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Lipitor, Atorvastatin (generic), Medication, Healthcare Industry, Cholesterol, Health, Pharmaceuticals, Merck , Zocor, Simvastatin (generic)

Seeking Alpha

Watson Has Double-Digit Upside, But Peers Are 'Strong Buys'

From high dividend yields to low betas, healthcare stocks are exceptionally safe.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Financial Markets, Johnson & Johnson, Johnson and Johnson, Johnson and Johnson Merck Consumer Pharmaceuticals, Pharmaceuticals

Thu May 10, 2012

Reuters

UPDATE 1-Drugmaker Mylan raises full-year profit view

Generic drugmaker Mylan Inc, which reported higher-than-expected earnings last month, raised its full-year profit outlook, saying it expects 2012 to be the best year in the company's history.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry

Forbes.com

TEVA's Q1 Effect on Specialty Pharma

"The quarter was mixed with concerns linked to weak EU result, lack of guidance update and a combination of the two.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Perrigo, Business News

Wed May 09, 2012

Freshnews

Watson Confirms LialdaA Patent Challenge

PARSIPPANY, N.J., May 9, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Healthcare Law, Law, Food and Drug Administration, Marketing

Los Angeles Jobs

Also on Topix